Eli Lilly takes aim at illicit market for its experimental weight-loss drug
CBS News · LC · trust 43/100
The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.
Read the original at CBS News →
Open in TruthVane →